NYSE$EHAB

Enhabit Inc · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

Enhabit reported Q2 2025 revenue of $266.1M, net income of $5.7M.

For Q2 2025, Enhabit reported Revenue was $266.1M, net income was $5.7M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $266.1M for Q2 2025.
  • Net income $5.7M.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$266M

Previous: $261M+2.1%
EPS

$0.10

Previous: $0.07+42.9%
Adjusted EBITDA

$26.9M

Previous: $25.2M+6.7%
Adjusted EBITDA Margin

10.1%

Previous: 9.7%+4.1%
Home Health Admissions

54.9K

Previous: 54.2K+1.3%
Home Health Cost per Visit

$94.70

Previous: $89.00+6.4%
Hospice Admissions

3.1K

Previous: 2.9K+8.7%
Hospice Patient Days

359.5K

Previous: 320.0K+12.3%
Hospice Average Daily Census

4.0K

Previous: 3.5K+12.3%
Hospice Revenue per Patient Day

$167.50

Previous: $157.50+6.3%
Hospice Cost per Patient Day

$78.70

Previous: $77.90+1.0%
Non-Medicare Admissions

31.8K

Previous: 30.2K+5.2%
Medicare Admissions

23.1K

Previous: 24.0K-3.7%
Completed Episodes

38.8K

Previous: 41.6K-6.7%
Revenue per Episode

$2.99K

Previous: $2.92K+2.2%
Visits per Episode

14.1

Previous: 14.4-2.1%
Total Home Health Visits

1.1M

Previous: 1.2M-5.2%
Non-Medicare Visits

570.4K

Previous: 581.3K-1.9%
Medicare Visits

546.9K

Previous: 597.7K-8.5%
Home Health ADC

42.1K

Previous: 41.9K+0.5%
Revenue per Patient Day

$53.70

Previous: $55.10-2.5%
Cost per Patient Day

$28.00

Previous: $28.00+0.0%
Capital Expenditures

-$2.2M

Previous: -$2.5M+12.0%
Free Cash Flow

$3M

No prior period
Net Income

$5.2M

Previous: -$200K+2700.0%
Operating Income

$16.7M

Previous: $11.2M+49.1%
Gross Profit

-$136M

Previous: $129M-205.2%
Cash & Equivalents

$37.1M

No prior period
Total Assets

$1.23B

No prior period

Revenue & EPS history

Enhabit · Revenue · Quarterly

$266M

Q2 2025+2.1%vs Q2 2024
Beat estimate in 3 of 4 quarters(75%)
ActualEstimate

Revenue by segment

Enhabit · $261M total across 2 segments · Q4 2024

  • Home Health
    $210M—
  • Hospice
    $51.1M—

Forward guidance

The quarterly filing discusses operating priorities, liquidity, and sector risks.

Tailwinds

  • MD&A outlines strategic priorities and capital allocation.
  • Segment commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 14 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

+1.9%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+8.6%

Avg return

30 days after

40%

6 / 15 earnings

Positive

+18.2%

Q1 2025

Best reaction

-6.1%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+0.1%—
Q4 2025+0.0%+0.0%+2.9%
Q3 2025-6.1%-2.7%+13.6%
Q2 2025+15.2%+11.4%+15.1%
Q1 2025+18.2%+27.7%+31.7%
Q4 2024+1.6%+2.3%+13.3%
Q3 2024-0.4%-5.7%-12.0%
Q2 2024+0.0%-3.1%+14.8%
Q1 2024+0.0%-5.4%-13.4%
Q4 2022+0.0%-5.7%-0.4%
Q3 2023+6.1%+6.7%+19.3%
Q2 2023-2.6%-2.9%+5.6%
Q1 2023-4.5%-6.0%-2.0%
Q3 2022-0.1%+1.9%+11.3%
Q2 2022+1.7%+5.1%+20.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro